Stockreport

Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]

Cabaletta Bio, Inc.  (CABA) 
PDF – 16 patients enrolled with 10 patients dosed as of November 12 across the RESET™ clinical development program; 40 U.S. clinical sites actively recruiting patients – [Read more]